Investor Relations

Disclosures under Regulation 62 of the SEBI Listing Regulations

Scheme of Arrangement

General Policies

Other Informations

Disclosures under Regulation 62 of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) Details of its business
2.	(b) Composition of the Board
3.	(c) Financial information including (i) notice of meeting of the board of directors where financial results shall be discussed; (ii) financial results, on the conclusion of the meeting of the board of directors where the financial results were approved; (iii) complete copy of the annual report including balance sheet, profit and loss account, directors report, corporate governance report etc;
4.	(d) contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances;
5.	(e) email address for grievance redressal and other relevant details;
6.	(f) name of the debenture trustees with full contact details;
7.	(g) the information, report, notices, call letters, circulars, proceedings, etc concerning non-convertible redeemable preference shares or non-convertible debt securities;
8.	(h) all information and reports including compliance reports filed by the listed entity;
9.	(i) Information with respect to the following: (i) default by issuer to pay interest or redemption amount; (ii) failure to create a charge on the assets
10.	(j) all credit ratings obtained by the entity for all its listed non-convertible securities, updated immediately upon any revision in the ratings
11.	(k) statements of deviation(s) or variation(s) as specified in sub-regulation (7) and sub-regulation (7A) of regulation 52 of these regulations;
12.	(l) annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) composition of the various committees of the board of directors;
2.	(b) terms and conditions of appointment of independent directors;
3.	(c) code of conduct of the board of directors and senior management personnel;
4.	(d) details of establishment of vigil mechanism/ whistle blower policy;
5.	(e) criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report;
6.	(f) secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations;
7.	(g) policy on dealing with related party transactions; debt securities;
8.	(h) policy for determining ‘material’ subsidiaries;
9.	(i) Details of familiarization programmes imparted to independent directors including the following details: (i) number of programmes attended by the independent directors (during the year and on a cumulative basis till date), (ii) number of hours spent by the independent directors in such programmes (during the year and on cumulative basis till date), and (iii) other relevant details.

Scheme of Arrangement

Title	Categories	Download
Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited	SchemeofArrangement
Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders	SchemeofArrangement
Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders	SchemeofArrangement
Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024	SchemeofArrangement
Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”)	SchemeofArrangement
Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12	SchemeofArrangement

General Policies

Other Informations

▼ Compliance under Regulation 7(2) and 7(3)

Title	Categories	Download
Compliance under Regulation 7(2) and 7(3)	Compliance under Regulation 7(2) and 7(3)

▼ Compliance under Regulation 13(3)

Title	Categories	Download
Compliance under Regulation 13(3) for the quarter ended March 2025	Compliance under Regulation 13(3)
Compliance under Regulation 13(3) for the quarter ended December, 2024	Compliance under Regulation 13(3)
Compliance under Regulation 13(3) for the quarter ended September, 2024	Compliance under Regulation 13(3)

▼ Compliance under Regulation 23 (9)

Title	Categories	Download
Related Party Transactions under Regulation 23(9) for the half year ended 31st March, 2025	Compliance under Regulation 23 (9)

▼ Compliance under Regulation 24(A)

▼ Compliance under Regulation 27

Title	Categories	Download
Compliance Report on Corporate Governance for the quarter and year ended 31st March 2025	Compliance under Regulation 27
Compliance Report on Corporate Governance for the quarter and half year ended 30th September, 2024	Compliance under Regulation 27

▼ Compliance under Regulation 61(4)

▼ Compliance Under Regulation 50 (1)

Title	Categories	Download
Intimation of Board Meeting dated 23 April 2025 under Regulation 50(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015	Compliance Under Regulation 50 (1)

▼ Compliance under Regulation 51

Title	Categories	Download
Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2025.	Compliance under Regulation 51
Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 31st March 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra as an Additional Director and Whole-time Director, Mr. Kaushik Roy, as an Additional Director and cessation of Mr. Kaushik Mukherjee, as a Whole-time Director & Mr. Raj Kumar Gupta, as a Director	Compliance under Regulation 51
Intimation of the 2nd EGM Notice of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) relating to Appointment of Ms. Iram Hassan as a Director (Non-Executive Independent Director) and Mr. Gopal Rathi (DIN: 00553066) as a Director (Non-Executive Director) of the Company	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra, as the Chief Executive Officer, KMP of the Company.	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Allotment of equity shares of Advaya Chemical Industries Limited (subsidiary of PCBL Chemical Limited) pursuant to conversion of unlisted optionally and fully convertible debentures	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Resignation of CS and CFO (KMPs) and Appointment of CS and CFO in place of resigning KMPs.	Compliance under Regulation 51
Intimation of the Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024	Compliance under Regulation 51
Intimation under Regulation 51(2) of the SEBI Listing Regulations read with Part B of Schedule III – Appointment of Mr. Gopal Rathi and Ms. Iram Hassan	Compliance under Regulation 51
Disclosures under Regulation 51 for Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company	Compliance under Regulation 51
Appt of IDs, Cessation of GR and Shifting of RO	Compliance under Regulation 51
Fine levied under Reg 6	Compliance under Regulation 51
Fine levied under Reg 6 (Reply)	Compliance under Regulation 51
Appt of CS	Compliance under Regulation 51
Appt of CFO & WTD	Compliance under Regulation 51
Submission of details of listed ISIN of Advaya Chemical Industries Limited for the half year ended 30th September, 2024 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May, 2024	Compliance under Regulation 51
Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders	Compliance under Regulation 51
Intimation of proceedings of the 1st EGM of Advaya Chemical Industries Limited	Compliance under Regulation 51
Intimation of Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2024	Compliance under Regulation 51
Intimation pursuant to Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Part B of Schedule III of SEBI Listing Regulations – Change in Auditor (Resignation of Statutory Auditor)	Compliance under Regulation 51

Rows per page: 1–5 of 22

▼ Compliance under Regulations 52

Title	Categories	Download
Financial Results for the quarter and year ended 31st March 2025	Compliance under Regulations 52
Financial Results for the quarter and nine months ended 31st December, 2024	Compliance under Regulations 52
Financials (31-03-2024)	Compliance under Regulations 52
Statement of Utilization of Issue Proceeds of NCD	Compliance under Regulations 52
Financials (30-06-2024)	Compliance under Regulations 52
Financials (30-09-2024)	Compliance under Regulations 52

▼ Compliance under Regulations 54

Title	Categories	Download
Asset Cover Details (31-03-2024)	Compliance under Regulations 54
Asset Cover Details (30-06-2024)	Compliance under Regulations 54
Asset Cover Details (30-09-2024)	Compliance under Regulations 54

▼Compliance under Regulations 55

Title	Categories	Download
Credit Rating on Rs. 550 Crore Non-Convertible Debentures of Advaya Chemical Industries Limited	Compliance under Regulations 55
Credit Rating on the Bank Facilities of Advaya Chemical Industries Limited.	Compliance under Regulations 55
Credit Rating Certificate obtained from CRISIL	Compliance under Regulations 55

▼Compliance under Regulation 57

Title	Categories	Download
Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – Advaya	Compliance under Regulation 57

▼Compliance under Regulation 53

Title	Categories	Download
Annual Report – FY 2023-24	Compliance under Regulation 53
Newspaper Advertisement – Publication of the Notice of the 1st Annual General Meeting and Book Closure Notice for the financial year ended 31st March, 2024	Compliance under Regulation 53
Financial Statements of Aquapharm Chemicals Private Limited	Compliance under Regulation 53
Draft Annual Return in Form MGT-7 for the FY 23-24	Compliance under Regulation 53
Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company	Compliance under Regulation 53

▼Compliance under Regulation 59A

Title	Categories	Download
Amalgamation Notice	Compliance under Regulation 59A

Disclosures under Regulation 62 of the SEBI Listing Regulations

Scheme of Arrangement

General Policies

Other Informations

Disclosures under Regulation 62 of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) Details of its business
2.	(b) Composition of the Board
3.	(c) Financial information including (i) notice of meeting of the board of directors where financial results shall be discussed; (ii) financial results, on the conclusion of the meeting of the board of directors where the financial results were approved; (iii) complete copy of the annual report including balance sheet, profit and loss account, directors report, corporate governance report etc;
4.	(d) contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances;
5.	(e) email address for grievance redressal and other relevant details;
6.	(f) name of the debenture trustees with full contact details;
7.	(g) the information, report, notices, call letters, circulars, proceedings, etc concerning non-convertible redeemable preference shares or non-convertible debt securities;
8.	(h) all information and reports including compliance reports filed by the listed entity;
9.	(i) Information with respect to the following: (i) default by issuer to pay interest or redemption amount; (ii) failure to create a charge on the assets
10.	(j) all credit ratings obtained by the entity for all its listed non-convertible securities, updated immediately upon any revision in the ratings
11.	(k) statements of deviation(s) or variation(s) as specified in sub-regulation (7) and sub-regulation (7A) of regulation 52 of these regulations;
12.	(l) annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) composition of the various committees of the board of directors;
2.	(b) terms and conditions of appointment of independent directors;
3.	(c) code of conduct of the board of directors and senior management personnel;
4.	(d) details of establishment of vigil mechanism/ whistle blower policy;
5.	(e) criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report;
6.	(f) secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations;
7.	(g) policy on dealing with related party transactions; debt securities;
8.	(h) policy for determining ‘material’ subsidiaries;
9.	(i) Details of familiarization programmes imparted to independent directors including the following details: (i) number of programmes attended by the independent directors (during the year and on a cumulative basis till date), (ii) number of hours spent by the independent directors in such programmes (during the year and on cumulative basis till date), and (iii) other relevant details.

Disclosures under Regulation 62 of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) Details of its business
2.	(b) Composition of the Board
3.	(c) Financial information including (i) notice of meeting of the board of directors where financial results shall be discussed; (ii) financial results, on the conclusion of the meeting of the board of directors where the financial results were approved; (iii) complete copy of the annual report including balance sheet, profit and loss account, directors report, corporate governance report etc;
4.	(d) contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances;
5.	(e) email address for grievance redressal and other relevant details;
6.	(f) name of the debenture trustees with full contact details;
7.	(g) the information, report, notices, call letters, circulars, proceedings, etc concerning non-convertible redeemable preference shares or non-convertible debt securities;
8.	(h) all information and reports including compliance reports filed by the listed entity;
9.	(i) Information with respect to the following: (i) default by issuer to pay interest or redemption amount; (ii) failure to create a charge on the assets
10.	(j) all credit ratings obtained by the entity for all its listed non-convertible securities, updated immediately upon any revision in the ratings
11.	(k) statements of deviation(s) or variation(s) as specified in sub-regulation (7) and sub-regulation (7A) of regulation 52 of these regulations;
12.	(l) annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Sl. No.	Particulars as per LODR
1.	(a) composition of the various committees of the board of directors;
2.	(b) terms and conditions of appointment of independent directors;
3.	(c) code of conduct of the board of directors and senior management personnel;
4.	(d) details of establishment of vigil mechanism/ whistle blower policy;
5.	(e) criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report;
6.	(f) secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations;
7.	(g) policy on dealing with related party transactions; debt securities;
8.	(h) policy for determining ‘material’ subsidiaries;
9.	(i) Details of familiarization programmes imparted to independent directors including the following details: (i) number of programmes attended by the independent directors (during the year and on a cumulative basis till date), (ii) number of hours spent by the independent directors in such programmes (during the year and on cumulative basis till date), and (iii) other relevant details.

Scheme of Arrangement

Title	Categories	Download
Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited	SchemeofArrangement
Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders	SchemeofArrangement
Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders	SchemeofArrangement
Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024	SchemeofArrangement
Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”)	SchemeofArrangement
Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12	SchemeofArrangement

General Policies

Other Informations

▼ Compliance under Regulation 7(2) and 7(3)

Title	Categories	Download
Compliance under Regulation 7(2) and 7(3)	Compliance under Regulation 7(2) and 7(3)

▼ Compliance under Regulation 13(3)

Title	Categories	Download
Compliance under Regulation 13(3) for the quarter ended March 2025	Compliance under Regulation 13(3)
Compliance under Regulation 13(3) for the quarter ended December, 2024	Compliance under Regulation 13(3)
Compliance under Regulation 13(3) for the quarter ended September, 2024	Compliance under Regulation 13(3)

▼ Compliance under Regulation 23 (9)

Title	Categories	Download
Related Party Transactions under Regulation 23(9) for the half year ended 31st March, 2025	Compliance under Regulation 23 (9)

▼ Compliance under Regulation 24(A)

▼ Compliance under Regulation 27

Title	Categories	Download
Compliance Report on Corporate Governance for the quarter and year ended 31st March 2025	Compliance under Regulation 27
Compliance Report on Corporate Governance for the quarter and half year ended 30th September, 2024	Compliance under Regulation 27

▼ Compliance under Regulation 61(4)

▼ Compliance Under Regulation 50 (1)

Title	Categories	Download
Intimation of Board Meeting dated 23 April 2025 under Regulation 50(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015	Compliance Under Regulation 50 (1)

▼ Compliance under Regulation 51

Title	Categories	Download
Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2025.	Compliance under Regulation 51
Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 31st March 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra as an Additional Director and Whole-time Director, Mr. Kaushik Roy, as an Additional Director and cessation of Mr. Kaushik Mukherjee, as a Whole-time Director & Mr. Raj Kumar Gupta, as a Director	Compliance under Regulation 51
Intimation of the 2nd EGM Notice of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) relating to Appointment of Ms. Iram Hassan as a Director (Non-Executive Independent Director) and Mr. Gopal Rathi (DIN: 00553066) as a Director (Non-Executive Director) of the Company	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra, as the Chief Executive Officer, KMP of the Company.	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Allotment of equity shares of Advaya Chemical Industries Limited (subsidiary of PCBL Chemical Limited) pursuant to conversion of unlisted optionally and fully convertible debentures	Compliance under Regulation 51
Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Resignation of CS and CFO (KMPs) and Appointment of CS and CFO in place of resigning KMPs.	Compliance under Regulation 51
Intimation of the Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024	Compliance under Regulation 51
Intimation under Regulation 51(2) of the SEBI Listing Regulations read with Part B of Schedule III – Appointment of Mr. Gopal Rathi and Ms. Iram Hassan	Compliance under Regulation 51
Disclosures under Regulation 51 for Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company	Compliance under Regulation 51
Appt of IDs, Cessation of GR and Shifting of RO	Compliance under Regulation 51
Fine levied under Reg 6	Compliance under Regulation 51
Fine levied under Reg 6 (Reply)	Compliance under Regulation 51
Appt of CS	Compliance under Regulation 51
Appt of CFO & WTD	Compliance under Regulation 51
Submission of details of listed ISIN of Advaya Chemical Industries Limited for the half year ended 30th September, 2024 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May, 2024	Compliance under Regulation 51
Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders	Compliance under Regulation 51
Intimation of proceedings of the 1st EGM of Advaya Chemical Industries Limited	Compliance under Regulation 51
Intimation of Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2024	Compliance under Regulation 51

▼ Compliance under Regulations 52

Title	Categories	Download
Financial Results for the quarter and year ended 31st March 2025	Compliance under Regulations 52
Financial Results for the quarter and nine months ended 31st December, 2024	Compliance under Regulations 52
Financials (31-03-2024)	Compliance under Regulations 52
Statement of Utilization of Issue Proceeds of NCD	Compliance under Regulations 52
Financials (30-06-2024)	Compliance under Regulations 52

▼ Compliance under Regulations 54

Title	Categories	Download
Asset Cover Details (31-03-2024)	Compliance under Regulations 54
Asset Cover Details (30-06-2024)	Compliance under Regulations 54
Asset Cover Details (30-09-2024)	Compliance under Regulations 54

▼Compliance under Regulations 55

Title	Categories	Download
Credit Rating on Rs. 550 Crore Non-Convertible Debentures of Advaya Chemical Industries Limited	Compliance under Regulations 55
Credit Rating on the Bank Facilities of Advaya Chemical Industries Limited.	Compliance under Regulations 55
Credit Rating Certificate obtained from CRISIL	Compliance under Regulations 55

▼Compliance under Regulation 57

Title	Categories	Download
Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – Advaya	Compliance under Regulation 57

▼Compliance under Regulation 53

Title	Categories	Download
Annual Report – FY 2023-24	Compliance under Regulation 53
Newspaper Advertisement – Publication of the Notice of the 1st Annual General Meeting and Book Closure Notice for the financial year ended 31st March, 2024	Compliance under Regulation 53
Financial Statements of Aquapharm Chemicals Private Limited	Compliance under Regulation 53
Draft Annual Return in Form MGT-7 for the FY 23-24	Compliance under Regulation 53
Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company	Compliance under Regulation 53

▼Compliance under Regulation 59A

Disclosures under Regulation 62 of the SEBI Listing Regulations

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Scheme of Arrangement

Disclosures under Regulation 62 of the SEBI Listing Regulations

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Disclosures under Regulation 62 of the SEBI Listing Regulations

Disclosures under Regulation 62(1A), of the SEBI Listing Regulations

Scheme of Arrangement

Section